145 related articles for article (PubMed ID: 37601432)
1.
Wong C; Calungsud LG; La MV
Access Microbiol; 2023; 5(7):. PubMed ID: 37601432
[TBL] [Abstract][Full Text] [Related]
2. Isolation of Bordetella trematum from the respiratory tract of a patient with lung cancer: a case report.
Kukla R; Svarc M; Bolehovska R; Ryskova L; Paterova P; Fajfr M; Malisova L; Zemlickova H
Folia Microbiol (Praha); 2020 Jun; 65(3):623-627. PubMed ID: 32189223
[TBL] [Abstract][Full Text] [Related]
3. Bordetella trematum infection: case report and review of previous cases.
Y Castro TR; Martins RCR; Dal Forno NLF; Santana L; Rossi F; Schwarzbold AV; Costa SF; Trindade PA
BMC Infect Dis; 2019 May; 19(1):485. PubMed ID: 31146691
[TBL] [Abstract][Full Text] [Related]
4. Detection and Characterization of Clinical
Buechler C; Neidhöfer C; Hornung T; Neuenhoff M; Parčina M
Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451430
[No Abstract] [Full Text] [Related]
5. A case of Bordetella trematum and Kerstersia gyiorum infections in a patient with congestive dermatitis.
Kitagawa D; Kurimoto T; Oyama S; Suzuki S; Masuo K; Suzuki Y; Nakano R; Sato M; Yano H; Maeda K; Nomi K; Nakamura F
J Infect Chemother; 2021 May; 27(5):740-746. PubMed ID: 33386260
[TBL] [Abstract][Full Text] [Related]
6. Erysipelas of the right arm due to Bordetella trematum: a case report.
Lacasse M; Inyambo K; Lemaignen A; Mennecart M; Gensburger S; Valentin AS; Bernard L; Fougère B
J Med Case Rep; 2021 Jul; 15(1):365. PubMed ID: 34253232
[TBL] [Abstract][Full Text] [Related]
7. Bordetella trematum sepsis with shock in a diabetic patient with rapidly developing soft tissue infection.
Majewski LL; Nogi M; Bankowski MJ; Chung HH
Diagn Microbiol Infect Dis; 2016 Sep; 86(1):112-4. PubMed ID: 27397578
[TBL] [Abstract][Full Text] [Related]
8. Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019.
Karlowsky JA; Lob SH; Khan A; Chen WT; Woo PCY; Seto WH; Ip M; Leung S; Wong QW; Chau RWY; DeRyke CA; Young K; Motyl MR; Sahm DF
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451945
[No Abstract] [Full Text] [Related]
9. Bordetella trematum in chronic ulcers: report on two cases and review of the literature.
Almagro-Molto M; Eder W; Schubert S
Infection; 2015 Aug; 43(4):489-94. PubMed ID: 25600927
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterisation of Bordetella hinzii in line-related bacteraemia and respiratory tract infection in Australia.
Sparks R; Painter A; Callum J; Swan C; Polkinghorne A; Fong W; Gall M; Sintchenko V; Branley J
Pathology; 2023 Feb; 55(1):117-122. PubMed ID: 36109195
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
Lu B; Wong M; Ha D; Bounthavong M; Banaei N; Deresinski S; Diep C
J Antimicrob Chemother; 2023 Apr; 78(4):1009-1014. PubMed ID: 36879495
[TBL] [Abstract][Full Text] [Related]
12. Imipenem-resistant Pseudomonas aeruginosa treated with piperacillin/tazobactam in a patient with severe pneumonia: a case report and related literature review.
He L; He A; Qian Y
Ann Palliat Med; 2021 Jan; 10(1):810-817. PubMed ID: 33545803
[TBL] [Abstract][Full Text] [Related]
13. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.
Harris PN; Peleg AY; Iredell J; Ingram PR; Miyakis S; Stewardson AJ; Rogers BA; McBryde ES; Roberts JA; Lipman J; Athan E; Paul SK; Baker P; Harris-Brown T; Paterson DL
Trials; 2015 Jan; 16():24. PubMed ID: 25623485
[TBL] [Abstract][Full Text] [Related]
14. [Accurate diagnosis of Pseudomonas luteola in routine microbiology laboratory: on the occasion of two isolates].
Çiçek M; Hasçelik G; Müştak HK; Diker KS; Şener B
Mikrobiyol Bul; 2016 Oct; 50(4):621-624. PubMed ID: 28124968
[TBL] [Abstract][Full Text] [Related]
15.
Karlowsky JA; Lob SH; Siddiqui F; Akrich B; DeRyke CA; Young K; Motyl MR; Hawser SP; Sahm DF
J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36763081
[No Abstract] [Full Text] [Related]
16. Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021).
Sader HS; Mendes RE; Arends SJR; Carvalhaes CG; Shortridge D; Castanheira M
Int J Antimicrob Agents; 2023 Apr; 61(4):106744. PubMed ID: 36738849
[TBL] [Abstract][Full Text] [Related]
17. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
[TBL] [Abstract][Full Text] [Related]
19. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
Sader HS; Castanheira M; Duncan LR; Mendes RE
Int J Infect Dis; 2021 Dec; 113():279-281. PubMed ID: 34670144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
